NuSkin Enterprises (NUS)

NYSEMarkedet er stengt

Nu Skin Enterprises, Inc. is a global beauty and wellness company that develops, markets, and sells personal care products, nutritional supplements, and related consumer technologies. The company is best known for the Nu Skin brand, which spans skin care, beauty devices, and anti-aging products, and Pharmanex, its wellness and nutrition line. Its products are distributed internationally through a direct selling model supported by independent sales leaders, social commerce tools, and local market operations.

Nu Skin reports its business across a broad geographic footprint that includes the Americas, Mainland China, Southeast Asia/Pacific, Japan, South Korea, Europe & Africa, and Hong Kong/Taiwan. This structure reflects the company’s reliance on local consumer preferences, regulatory environments, and distributor networks in each region. The Americas segment is a particularly important contributor, and wellness products represent a major part of total revenue.

Beyond its core branded consumer business, Nu Skin operates Rhyz, a strategic investment and operating platform. Rhyz includes manufacturing and packaging assets that support product development and supply chain capabilities, as well as other investments intended to broaden the company’s commercial reach. This gives Nu Skin exposure not only to consumer-facing beauty and wellness categories, but also to parts of the production infrastructure behind them.

The company competes in markets shaped by health-conscious consumers, premium skin care demand, and the growth of digital selling. Its performance depends on product innovation, brand engagement, distributor productivity, and the ability to navigate changing rules for direct selling and consumer products across global markets.

4.85USD
4.85 USD
+0.08(+1.68%)
Etter stengetid

Sist oppdatert

Markedsverdi
$232,187,544
P/E-tall
P/FCF-tall
21.54
P/S-tall
0.17
Selskapsverdi
$256,208,544
Sektor
Consumer Staples
Bransje
Personal Care Products
Adresse
75 WEST CENTER ST, PROVO, UT, 84601

Ingen nylige nyheter er knyttet til denne noteringen.

Markedsverdi
$232,187,544
Selskapsverdi
$256,208,544
P/E-tall
P/B-tall
0.43
P/S-tall
0.17
EV / EBITDA-forhold
2.13
EV / omsetning
0.19
Resultat per aksje
-4.45
Utbytterente
5.02%
P/FCF-tall
21.54
P/CF-tall
4.57
Fri kontantstrøm
$10,781,000
Avkastning på egenkapital
-39.87%
Avkastning på eiendeler
-19.29%
Gjeld / egenkapital
0.39
Likviditetsgrad I
1.98
Likviditetsgrad II
1.24
Kontanter
0.74
Snittvolum
$580,238
Fundamentalpris (snapshot)
4.77

Resultatregnskap

Post2026 Q22026 Q12025 Q42025 Q32025 Q2
Omsetning320.11M320.61M370.32M364.21M386.14M
Cost of revenue101.79M106.15M108.34M107.49M120.41M
Bruttofortjeneste218.33M214.46M261.98M256.72M265.73M
Driftsresultat-59.32M4.03M23.24M21.64M30.78M
Driftsresultat før avskrivninger (EBITDA)32.21M18.21M36.16M33.73M43.83M
Nettoresultat-249.8M1.84M14.49M17.08M21.12M
Income taxes186.62M763K3.7M-1.09M6.29M
Interest expense-3.32M-4.25M-3.99M-4.15M-2.53M
Other operating expenses78.88M1.84M000
Total operating expenses277.64M210.44M238.74M235.08M234.95M
Grunnleggende EPS-5.140.040.30.350.43
Utvanet EPS-5.140.040.280.340.43

Balanse

Post2026 Q22026 Q12025 Q42025 Q32025 Q2
Sum eiendeler1.12B1.38B1.41B1.42B1.44B
Sum gjeld578.79M582.71M600.07M624.61M655.94M
Egenkapital542.74M794.09M805.24M799.8M787.75M
Kontanter og ekvivalenter189.64M198.65M238.63M251.79M264.16M
Omløpsmidler508.15M522.89M547.7M548.14M571.55M
Kortsiktig gjeld256.35M257M263.73M254.44M283.91M
Accounts payable37.71M28.82M26.18M28.52M28.73M
Receivables48.9M45.01M39.54M48.89M59.7M
Inventories191.5M178.6M178.64M178.53M180.38M
Goodwill4.75M83.63M83.63M83.63M83.63M
Long-term debt193.66M203.59M204.19M209.04M213.9M

Kontantstrøm

Post2026 Q22026 Q12025 Q42025 Q32025 Q2
Kontantstrøm fra drift10.63M-3.92M16.62M27.48M35.8M
Kontantstrøm fra investeringer-5.64M-14.29M-9.76M-9.92M8.79M
Kontantstrøm fra finansiering-13.38M-20.4M-18.5M-26.88M9.27M
Endring i kontanter-9.01M-39.98M-13.16M-12.37M60.39M
Nettoresultat-249.8M1.84M14.49M17.08M21.12M
TypeRapportDatoLenke
edgar index8-K — NU SKIN ENTERPRISES, INC.Vis rapport
eight k text8-K — 8-KVis rapport
edgar index8-K — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index10-Q — NU SKIN ENTERPRISES, INC.Vis rapport
eight k text8-K — 8-KVis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
form 4Form 4 — WOODBURY EDWINA DVis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index144 — NU SKIN ENTERPRISES, INC.Vis rapport
form 4Form 4 — Winett James MVis rapport
edgar indexS-8 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index144 — NU SKIN ENTERPRISES, INC.Vis rapport
form 4Form 4 — CAMPBELL DANIEL WVis rapport
form 4Form 4 — CAMPBELL DANIEL WVis rapport
form 4Form 4 — CAMPBELL DANIEL WVis rapport
form 4Form 4 — Thomas Pisano R.Vis rapport
form 4Form 4 — Battle Emma S.Vis rapport
form 4Form 4 — WOODBURY EDWINA DVis rapport
form 4Form 4 — WOODBURY EDWINA DVis rapport
form 4Form 4 — Zorko Mark AVis rapport
form 4Form 4 — Nathanson LauraVis rapport
form 4Form 4 — Winett James MVis rapport
edgar index8-K — NU SKIN ENTERPRISES, INC.Vis rapport
eight k text8-K — 8-KVis rapport
edgar indexSD — NU SKIN ENTERPRISES, INC.Vis rapport
edgar indexSCHEDULE 13G/A — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index144 — NU SKIN ENTERPRISES, INC.Vis rapport
form 4Form 4 — Nathanson LauraVis rapport
edgar index10-Q — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index8-K — NU SKIN ENTERPRISES, INC.Vis rapport
eight k text8-K — 8-KVis rapport
edgar index8-K — NU SKIN ENTERPRISES, INC.Vis rapport
eight k text8-K — 8-KVis rapport
edgar indexDEF 14A — NU SKIN ENTERPRISES, INC.Vis rapport
edgar indexDEFA14A — NU SKIN ENTERPRISES, INC.Vis rapport
edgar indexARS — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index3 — NU SKIN ENTERPRISES, INC.Vis rapport
form 3Form 3 — Lantz Chelsea KVis rapport
edgar indexSCHEDULE 13G/A — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index8-K — NU SKIN ENTERPRISES, INC.Vis rapport
eight k text8-K — 8-KVis rapport
edgar index8-K — NU SKIN ENTERPRISES, INC.Vis rapport
eight k text8-K — 8-KVis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
form 4Form 4 — WOODBURY EDWINA DVis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index8-K — NU SKIN ENTERPRISES, INC.Vis rapport
eight k text8-K — 8-KVis rapport
form 4Form 4 — NAPIERSKI RYAN SVis rapport
form 4Form 4 — Thomas James DVis rapport
form 4Form 4 — Clark Chayce DavidVis rapport
form 4Form 4 — Hatchett Steven KeithVis rapport
form 4Form 4 — Keisel Justin SVis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport
form 4Form 4 — NAPIERSKI RYAN SVis rapport
form 4Form 4 — Thomas James DVis rapport
form 4Form 4 — Clark Chayce DavidVis rapport
form 4Form 4 — Hatchett Steven KeithVis rapport
form 4Form 4 — Keisel Justin SVis rapport
edgar index4 — NU SKIN ENTERPRISES, INC.Vis rapport